These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3296134)

  • 41. Insulin secretion defects in liver cirrhosis can be reversed by glucagon-like peptide-1.
    Siegel EG; Seidenstücker A; Gallwitz B; Schmitz F; Reinecke-Lüthge A; Klöppel G; Fölsch UR; Schmidt WE
    J Endocrinol; 2000 Jan; 164(1):13-9. PubMed ID: 10607933
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study of carbohydrate metabolism in postnecrotic cirrhosis liver.
    Yeung RT; Wang CC
    Gut; 1974 Nov; 15(11):907-12. PubMed ID: 4455570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity.
    Ward GM; Walters JM; Aitken PM; Best JD; Alford FP
    Diabetes; 1990 Apr; 39(4):501-7. PubMed ID: 2180760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring the effect of a study meal on portal concentrations of glucagon-like peptide 1 (GLP-1) in non diabetic and diabetic patients with liver cirrhosis: transjugular intrahepatic portosystemic stent shunt (TIPSS) as a new method for metabolic measurements.
    Raddatz D; Nolte W; Rossbach C; Leonhardt U; Buchwald A; Scholz KH; Ramadori G
    Exp Clin Endocrinol Diabetes; 2008 Aug; 116(8):461-7. PubMed ID: 18770489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysregulation of plasma ghrelin in alcoholic cirrhosis.
    Goodyear SJ; Mottershead M; Sung EZ; Wong LS; McTernan PG; Kumar S; Nwokolo CU
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):323-9. PubMed ID: 20184601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo insulin action in hepatocellular and cholestatic liver cirrhosis.
    Barzilai N; Cohen P; Karnieli E; Enat R; Epstein O; Owen J; McIntyre N
    J Endocrinol Invest; 1991 Oct; 14(9):727-35. PubMed ID: 1761807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin action in cirrhosis.
    Taylor R; Heine RJ; Collins J; James OF; Alberti KG
    Hepatology; 1985; 5(1):64-71. PubMed ID: 3881332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin resistance and delayed clearance of peptide hormones in cirrhotic rat liver.
    Shankar TP; Drake S; Solomon SS
    Am J Physiol; 1987 Jun; 252(6 Pt 1):E772-7. PubMed ID: 3296781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucose resistance contributes to diabetes mellitus in cirrhosis.
    Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
    Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin and glucagon degradation in liver are not affected by hepatic cirrhosis.
    Antoniello S; La Rocca S; Cavalcanti E; Auletta M; Salvatore F; Cacciatore L
    Clin Chim Acta; 1989 Aug; 183(3):343-50. PubMed ID: 2680168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enteral versus parenteral glucose as the sole nutritional support after colorectal resection. A prospective, randomized comparison.
    Magnússon J; Tranberg KG; Jeppsson B; Lunderquist A
    Scand J Gastroenterol; 1989 Jun; 24(5):539-49. PubMed ID: 2503865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucoregulatory response to insulin-induced hypoglycemia in Laennec's cirrhosis.
    Perez G; Trimarco B; Ungaro B; Rengo F; Saccà L
    J Clin Endocrinol Metab; 1978 May; 46(5):778-83. PubMed ID: 400562
    [No Abstract]   [Full Text] [Related]  

  • 55. Amino acid modulation of glucose-induced insulin and glucagon release in diabetic patients.
    Seino Y; Ikeda M; Nakane K; Nakahara H; Seino S
    Metabolism; 1977 Aug; 26(8):911-9. PubMed ID: 875735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations.
    Nielsen MF; Caumo A; Aagaard NK; Chandramouli V; Schumann WC; Landau BR; Schmitz O; Vilstrup H
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1135-43. PubMed ID: 15637182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Incretory function of the pancreas in alcoholic liver diseases].
    Loginov AS; Vysotskaia RA
    Vopr Med Khim; 1988; 34(1):105-9. PubMed ID: 3285585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Muscarinic cholinergic modulation of insulin response to an intravenous glucose tolerance test in normal man.
    Coiro V; Chiodera P; Volpi R; d'Amato L; Camellini L; Rossi G; Pignatti D; Butturini U
    J Endocrinol Invest; 1986 Feb; 9(1):27-30. PubMed ID: 3517121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.